Medical expert of the article
New publications
Prostate cancer (prostate cancer) - Prognosis
Last reviewed: 04.07.2025
All iLive content is medically reviewed or fact checked to ensure as much factual accuracy as possible.
We have strict sourcing guidelines and only link to reputable media sites, academic research institutions and, whenever possible, medically peer reviewed studies. Note that the numbers in parentheses ([1], [2], etc.) are clickable links to these studies.
If you feel that any of our content is inaccurate, out-of-date, or otherwise questionable, please select it and press Ctrl + Enter.
Prostate cancer: the prognosis of the disease is usually favorable, provided that prostate cancer is detected early and surgery is performed in a timely manner.
The prognosis for prostate cancer at stages I and II is that the 5-year survival rate of a patient after radical prostatectomy is 74–85%, and the 10-year survival rate is 55–56%.
The prognosis for prostate cancer with the use of radiation therapy is a 5-year survival rate of 72-80% of patients, and a 10-year survival rate of 48%. Unfortunately, prostate cancer is often detected at late stages (stages III-IV), which makes the prognosis unfavorable due to the occurrence of multiple metastatic foci in other organs of the body (5-year survival for prostate cancer at stage III is 50%, at stage IV - 20%).
The prognosis of prostate cancer is also influenced by the man's age, the presence of concomitant diseases, the level of PSA ploidy of prostate cancer cells in the blood serum, the adequacy of treatment measures and the quality of patient monitoring.
Stage A1: Usually untreated, prostate cancer (prostate cancer) progresses in 0-15% of cases.
Stage A2. The 5-year survival rate of patients (without progression) is more than 90% (with treatment).
- External beam radiation therapy (may be used 4 to 6 weeks after transurethral resection of the prostate).
- Radical prostatectomy with pelvic lymphadenectomy.
- Dynamic observation of the patient without specific treatment.
Stage B1. 5-year survival without progression of prostate cancer (prostate cancer) with treatment is 85%, 10-year - 50%,
Stage B2. 10-year survival rate is 37%.
- Radical prostatectomy with pelvic lymphadenectomy and radiotherapy.
- External beam radiation therapy for prostate cancer.
- Dynamic observation of the patient without specific treatment.
Stage C. 5-year survival without progression of prostate cancer (prostate cancer) with treatment is 48%.
External beam radiation therapy for prostate cancer.
- Radical prostatectomy with pelvic lymphadenectomy.
- Palliative treatment of prostate cancer (radiation therapy, transurethral resection of the prostate, hormone therapy)
Stage D. 5-year survival without progression of prostate cancer (prostate cancer) with treatment is 21%.
- Palliative treatment of prostate cancer (radiation therapy, transurethral resection of the prostate, hormone therapy).
[